Sage Journals: Discover world-class research

Abstract

Background

Morbid adherent placenta, a severe pregnancy complication, is associated with massive obstetrical haemorrhage and high maternal mortality. Antenatal diagnosis and meticulous multidisciplinary planning at delivery is crucial for optimal outcome. We aim to identify the maternal and neonatal outcome in women with morbid adherent placenta.

Method

It was a retrospective evaluation of cases of clinically suspected and/or histologically confirmed morbid adherent placenta over a 1-year period.

Results

The incidence of morbid adherent placenta was 1 per 306 deliveries. Previous Caesarean section with placenta praevia was the commonest risk factor. Among all, 71.4% had no antenatal care. Of all, 38.9% women needed transfer to critical care. There were five (23.8%) maternal deaths. Of the 21 neonates, four were stillborn, nine needed NICU transfer and eight had an Apgar score of 9 at 5 min of birth.

Conclusion

Morbid adherent placenta is associated with poor maternal and neonatal outcome.

Keywords

Asia pregnancy

Get full access to this article

View all access options for this article.

References

Miller

Chollet

Goodwin

. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol 1997; 177: 210–214.

Kocherginsky

Hibbard

. Abnormal placentation: Twenty year analysis. Am J Obstet Gynecol 2005; 192: 1458–1461.

Wortman

Alexander

. Placenta accreta, increta, and percreta. Obstet Gynaecol Clin N Am 2013; 40: 137–154.

Park K. Park’s Textbook of preventive and social medicine. 22nd edn. Jabalpur: Banarsidas Bhanot; 2013.

Gupta

. Comprehensive bulletin on Safe Motherhood Initiative. Safe motherhood committee – FOGSI 2014; 7: 70–78.

Jwarah

Wilkin

. Conservative management of placenta accreta. J Obstet Gynecol 2006; 26: 378–379.

Publications Committee, Society for Maternal Fetal Medicine, Belfort

. Placenta accreta. Am J Obstet Gynecol 2010; 203: 430–439.

Gielchinsky

Rojansky

Fasouliotis

Ezra

. Placenta accreta–summary of 10 years: a survey of 310 cases. Placenta 2002; 23: 210–214.

Silver

Landon

Rouse

Leveno

Spong

Thom

. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006; 107: 1226–1232.

10.

Bajwa

Singh

Bajwa

. Contemporary issues in the management of abnormal placentation during pregnancy in developing nations: An Indian perspective. Int J Crit Illn Inj Sci 2013; 3: 183–189.

11.

Dibbs

Ball

Huettner

. Spontaneous uterine rupture and hemoperitoneum in the first trimester. Am J Perinatol 1995; 12: 439–441.

12.

Kim

Han

Choi

Ahn

Yang

Kang

. Oral misoprostol and uterine rupture in the first trimester of pregnancy: A case report. Reprod Toxicol 2005; 20: 575–577.

13.

Jwarah

Greenhalf

. Rupture of the uterus after 800 micrograms misoprostol given vaginally for termination of pregnancy. BJOG 2000; 107: 807–807.

14.

Gao

Wang

. Clinical observation on termination of early pregnancy of 213 cases after caesarean section with repeated use of mifepristone and misoprostol. Reprod Contracept 1999; 10: 227–233.

15.

Chen

. Termination of early pregnancy in the scarred uterus with mifepristone and misoprostol. Int J Gynaecol Obstet 2001; 72: 245–251.

16.

World Health Organization. Appropriate technology for birth. Lancet 1985; 2: 436–437.

17.

Verkuyl DAA. FIGO’s ethical recommendations on female sterilization will do more harm than good: a commentary. J Med Ethics 2013. DOI: 10.1136/medethics-2013-101827.